NASDAQ:HSKA Heska (HSKA) Stock Price, News & Analysis → Bigger Than NVIDIA? (From Behind the Markets) (Ad) Free HSKA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$119.99▼$119.9950-Day Range$115.55▼$119.9952-Week Range$57.83▼$120.03VolumeN/AAverage Volume241,932 shsMarket Capitalization$1.31 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Heska alerts: Email Address Ad Weiss RatingsReclusive millionaire’s final warning about AmericaThis crisis that's likly to begin in this country — before the election — could be bigger and more destructive than any crisis I've ever seen. That's why, no matter what you do, make sure you watch my short video and learn the three steps you need to take right now.Click here to learn how to prepare before it's too late. About Heska Stock (NASDAQ:HSKA)Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.Read More Ad Weiss RatingsReclusive millionaire’s final warning about AmericaThis crisis that's likly to begin in this country — before the election — could be bigger and more destructive than any crisis I've ever seen. That's why, no matter what you do, make sure you watch my short video and learn the three steps you need to take right now.Click here to learn how to prepare before it's too late. HSKA Stock News HeadlinesJanuary 2, 2024 | marketwatch.comVolitionRx Shares Up 35% on $13M Milestone Payments From HeskaOctober 31, 2023 | thestreet.comWhy Heska (HSKA) Hit a One-Year High TodayJune 18, 2024 | Prosper Trading Academy (Ad)Beta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and finds hot stocks that you probably have never even heard of… …it recommends the best potential strategy to use on the names it finds (with historical data to prove it)June 8, 2023 | markets.businessinsider.comWhy eXp World Holdings Shares Are Rising ThursdayMay 19, 2023 | msn.comHeska Earnings Perspective: Return On Capital EmployedMay 11, 2023 | businesswire.comHESKA CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Heska ...May 9, 2023 | finance.yahoo.comStrong Fourth Quarter Results Supported Heska Corporation (HSKA) in Q1May 5, 2023 | finance.yahoo.comHeska (HSKA) Q1 Earnings and Revenues Lag EstimatesJune 18, 2024 | Prosper Trading Academy (Ad)Beta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and finds hot stocks that you probably have never even heard of… …it recommends the best potential strategy to use on the names it finds (with historical data to prove it)May 5, 2023 | finance.yahoo.comHeska Corporation Reports First Quarter 2023 ResultsApril 21, 2023 | finance.yahoo.comHeska Announces Annual Meeting of Stockholders on May 3, 2023April 4, 2023 | finance.yahoo.comThe three-year returns have been strong for Heska (NASDAQ:HSKA) shareholders despite underlying losses increasingApril 3, 2023 | finance.yahoo.comWhy Heska Stock Is On Fire TodayApril 3, 2023 | finance.yahoo.comMars to Acquire Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty SolutionsMarch 1, 2023 | finance.yahoo.comHeska (HSKA) Q4 Earnings and Revenues Surpass EstimatesMarch 1, 2023 | finance.yahoo.comHeska Full Year 2022 Earnings: EPS Misses ExpectationsMarch 1, 2023 | finance.yahoo.comAt US$81.43, Is It Time To Put Heska Corporation (NASDAQ:HSKA) On Your Watch List?February 28, 2023 | finance.yahoo.comHeska Corporation Reports Fourth Quarter and Full Year 2022 ResultsFebruary 23, 2023 | finance.yahoo.comHeska to Present at Three Upcoming Institutional Investor ConferencesFebruary 13, 2023 | finance.yahoo.comHeska (HSKA) Moves to Buy: Rationale Behind the UpgradeFebruary 8, 2023 | finance.yahoo.comHeska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023January 18, 2023 | finance.yahoo.comIs There An Opportunity With Heska Corporation's (NASDAQ:HSKA) 50% Undervaluation?January 12, 2023 | gurufocus.comHeska Corp's CEO Loads Up on Shares After 70% NosediveJanuary 11, 2023 | finance.yahoo.comHeska (HSKA) Moves 9.0% Higher: Will This Strength Last?January 3, 2023 | finance.yahoo.comHeska Corporation Completes Acquisition of LightDeck DiagnosticsDecember 23, 2022 | finance.yahoo.comHeska to Participate in the 41st J.P. Morgan Annual Healthcare ConferenceNovember 8, 2022 | finance.yahoo.comHeska Corporation Reports Third Quarter 2022 ResultsSee More Headlines Receive HSKA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heska and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today6/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:HSKA CUSIPN/A CIK1038133 Webwww.heska.com Phone(970) 493-7272Fax970-619-3003Employees808Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.93) Trailing P/E RatioN/A Forward P/E Ratio266.64 P/E GrowthN/ANet Income$-19,890,000.00 Net Margins-7.86% Pretax Margin-7.91% Return on Equity0.94% Return on Assets0.67% Debt Debt-to-Equity Ratio0.23 Current Ratio5.64 Quick Ratio4.12 Sales & Book Value Annual Sales$257.31 million Price / Sales5.09 Cash Flow$1.69 per share Price / Cash Flow70.99 Book Value$39.00 per share Price / Book3.08Miscellaneous Outstanding Shares10,910,000Free Float9,572,000Market Cap$1.31 billion OptionableNot Optionable Beta1.58 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Kevin S. Wilson (Age 51)CEO, Pres & Director Comp: $988.17kMs. Catherine I. Grassman CPA (Age 47)Exec. VP & CFO Comp: $536.46kMr. Christopher D. Sveen (Age 40)EVP, Chief Admn. Officer, Gen. Counsel, Corp. Sec. & Pres of Diamond Animal Health Comp: $457.89kMr. Steven M. Eyl (Age 57)Exec. VP, Chief Commercial Officer & Pres of scil animal care company Comp: $475.28kMs. Eleanor F. Baker (Age 38)Exec. VP, MD & COO of Scil Animal Care Company Comp: $467.77kMr. Jon AagaardDirector of Investor RelationsMr. Anthony C. Providenti Jr. (Age 56)Exec. VP of Corp. Devel. Dr. Nancy Wisnewski Ph.D. (Age 60)Chief Science Advisor to CEO Daniel J. PollackVP of Imaging Operations, Treasurer & Assistant Sec.Cynthia PattersonVP of Customer CareMore ExecutivesKey CompetitorsMeridian BioscienceNASDAQ:VIVOCelldex TherapeuticsNASDAQ:CLDXAspira Women's HealthNASDAQ:AWHAinosNASDAQ:AIMDWBone BiologicsNASDAQ:BBLGWView All Competitors HSKA Stock Analysis - Frequently Asked Questions How were Heska's earnings last quarter? Heska Co. (NASDAQ:HSKA) issued its quarterly earnings results on Thursday, November, 4th. The medical research company reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by $0.23. The medical research company earned $60.24 million during the quarter, compared to analyst estimates of $63.80 million. Heska had a negative net margin of 7.86% and a positive trailing twelve-month return on equity of 0.94%. Heska's revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.25) earnings per share. What is Kevin S. Wilson's approval rating as Heska's CEO? 5 employees have rated Heska Chief Executive Officer Kevin S. Wilson on Glassdoor.com. Kevin S. Wilson has an approval rating of 57% among the company's employees. This puts Kevin S. Wilson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Heska own? Based on aggregate information from My MarketBeat watchlists, some companies that other Heska investors own include Gilead Sciences (GILD), Exxon Mobil (XOM), Netflix (NFLX), Biogen (BIIB), AbbVie (ABBV), Amgen (AMGN), Broadcom (AVGO), Alibaba Group (BABA), Exelixis (EXEL) and Merck & Co., Inc. (MRK). This page (NASDAQ:HSKA) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages...Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heska Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heska With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.